Analyst Ratings for Taysha Gene Therapies (TSHA)
TSHA Rating Summary
TSHA Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.57 (+167.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$6.57 (+167.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/9/2024 | Piper Sandler | Christopher Raymond | New Coverage | Overweight (N/A) |
9.00 (N/A) |
2.68 (2.46) |
-8.21% | Details |
| 2/2/2023 | BTIG | Yun Zhong | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.64 (2.46) |
50% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
